Publicaciones en colaboración con investigadores/as de Instituto Cajal (8)

2024

  1. The CB1 receptor interacts with cereblon and drives cereblon deficiency-associated memory shortfalls

    EMBO Molecular Medicine, Vol. 16, Núm. 4, pp. 755-783

2021

  1. Effects of Gαi2 and Gαz protein knockdown on alpha2A-adrenergic and cannabinoid CB1 receptor regulation of MEK-ERK and FADD pathways in mouse cerebral cortex

    Pharmacological Reports, Vol. 73, Núm. 4, pp. 1122-1135

2020

  1. Long-term hippocampal interneuronopathy drives sex-dimorphic spatial memory impairment induced by prenatal THC exposure

    Neuropsychopharmacology, Vol. 45, Núm. 5, pp. 877-886

2017

  1. Schizophrenia and depression, two poles of endocannabinoid system deregulation

    Translational Psychiatry, Vol. 7, Núm. 12

2013

  1. Chronic pain leads to concomitant noradrenergic impairment and mood disorders

    Biological Psychiatry, Vol. 73, Núm. 1, pp. 54-62

2012

  1. The function of alpha-2-adrenoceptors in the rat locus coeruleus is preserved in the chronic constriction injury model of neuropathic pain

    Psychopharmacology, Vol. 221, Núm. 1, pp. 53-65

2002

  1. Antinociceptive, behavioural and neuroendocrine effects of CP 55,940 in young rats

    Developmental Brain Research, Vol. 136, Núm. 2, pp. 85-92

  2. Effects of 14-methoxymetopon, a potent opioid agonist, on the responses to the tail electric stimulation test and plus-maze activity in male rats: Neuroendocrine correlates

    Brain Research Bulletin, Vol. 57, Núm. 5, pp. 661-666